4//SEC Filing
Corey Lawrence 4
Accession 0001415889-25-010437
CIK 0001656634other
Filed
Apr 7, 8:00 PM ET
Accepted
Apr 8, 8:57 PM ET
Size
11.0 KB
Accession
0001415889-25-010437
Insider Transaction Report
Form 4
Corey Lawrence
Director
Transactions
- Other
Stcok Option (right to buy)
2025-04-04−38,000→ 0 totalExercise: $4.10Exp: 2032-08-11→ Common Stock (38,000 underlying) - Other
Stock Option (Right to Buy)
2025-04-04−51,800→ 0 totalExercise: $0.76Exp: 2034-06-16→ Common Stock (51,800 underlying) - Other
Stock Option (Right to Buy)
2025-04-04−51,800→ 0 totalExercise: $2.19Exp: 2033-06-15→ Common Stock (51,800 underlying)
Footnotes (4)
- [F1]Pursuant to the Issuer's Second Modified Plan of Reorganization pursuant to Chapter 11 of the Bankruptcy Code, which was confirmed by the United States Bankruptcy Court for the District of Delaware on April 3, 2025 and became effective on April 4, 2025, each share of the Issuer's common stock and options to purchase the Issuer's common stock outstanding prior to the Issuer's emergence from bankruptcy were cancelled for no value.
- [F2]The options are fully vested.
- [F3]The option will vest and become exercisable on the earlier of (i) the first anniversary of the date of grant or (ii) the date of the next annual stockholder's meeting to the extent unvested as of such date, subject to continued service through the applicable vesting date.
- [F4]The Stock Option shall vest and become exercisable as to 1/36 of the total number of shares subject thereto on each monthly anniversary of the grant date such that the entire number of shares subject to the Stock Option are fully vested and exercisable on the third anniversary of the grant date, subject to Reporting Person's continuing service on the Issuer's board of directors through each vesting date.
Documents
Issuer
Gritstone bio, Inc.
CIK 0001656634
Entity typeother
Related Parties
1- filerCIK 0001942990
Filing Metadata
- Form type
- 4
- Filed
- Apr 7, 8:00 PM ET
- Accepted
- Apr 8, 8:57 PM ET
- Size
- 11.0 KB